VIEMED HEALTHCARE, INC. Operating Income
VIEMED HEALTHCARE, INC. (VMD) reported Operating Income of $4.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-03
- VIEMED HEALTHCARE, INC. operating income (loss) for the quarter ending 2026-06-30 was $4.46M, a 12.44% decline year-over-year.
- VIEMED HEALTHCARE, INC. operating income (loss) for the quarter ending 2026-03-31 was $4.30M, a 11.85% increase year-over-year.
- VIEMED HEALTHCARE, INC. operating income (loss) for the quarter ending 2025-12-31 was $8.37M, a 29.74% increase year-over-year.
- VIEMED HEALTHCARE, INC. operating income (loss) for the quarter ending 2025-09-30 was $5.64M, a 0.25% increase year-over-year.
- VIEMED HEALTHCARE, INC. operating income (loss) for fiscal 2025 was $22.95M, a 28.21% increase from fiscal 2024.
- VIEMED HEALTHCARE, INC. operating income (loss) for fiscal 2024 was $17.90M, a 24.91% increase from fiscal 2023.
- VIEMED HEALTHCARE, INC. operating income (loss) for fiscal 2023 was $14.33M, a 73.65% increase from fiscal 2022.
- VIEMED HEALTHCARE, INC. operating income (loss) for fiscal 2022 was $8.25M, a 28.74% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.46M 10-Q · filed 2026-08-03 | $8.76M 10-Q · filed 2026-08-03 | $17.13M derived: sum of 3 quarters · filed 2026-08-03 | $22.77M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2026-03-31 | $4.30M 10-Q · filed 2026-05-05 | $12.67M derived: sum of 2 quarters · filed 2026-05-05 | $18.31M derived: sum of 3 quarters · filed 2026-05-05 | $23.40M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-12-31 | $8.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $14.01M derived: sum of 2 quarters · filed 2026-03-04 | $19.11M derived: sum of 3 quarters · filed 2026-08-03 | $22.95M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $5.64M 10-Q · filed 2025-11-05 | $10.74M derived: sum of 2 quarters · filed 2026-08-03 | $14.58M 10-Q · filed 2025-11-05 | $21.03M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-06-30 | $5.09M 10-Q · filed 2026-08-03 | $8.94M 10-Q · filed 2026-08-03 | $15.39M derived: sum of 3 quarters · filed 2026-08-03 | $21.02M derived: sum of 4 quarters · filed 2026-08-03 | ||||
| 2025-03-31 | $3.84M 10-Q · filed 2026-05-05 | $10.29M derived: sum of 2 quarters · filed 2026-05-05 | $15.92M derived: sum of 3 quarters · filed 2026-05-05 | $19.54M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $12.08M derived: sum of 2 quarters · filed 2026-03-04 | $15.70M derived: sum of 3 quarters · filed 2026-03-04 | $17.90M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $5.63M 10-Q · filed 2025-11-05 | $9.24M derived: sum of 2 quarters · filed 2025-11-05 | $11.45M 10-Q · filed 2025-11-05 | $16.74M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-06-30 | $3.62M 10-Q · filed 2025-08-06 | $5.82M 10-Q · filed 2025-08-06 | $11.11M derived: sum of 3 quarters · filed 2026-03-04 | $15.31M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2024-03-31 | $2.20M 10-Q · filed 2025-05-07 | $7.49M derived: sum of 2 quarters · filed 2026-03-04 | $11.70M derived: sum of 3 quarters · filed 2026-03-04 | $14.60M derived: sum of 4 quarters · filed 2026-03-04 | ||||
| 2023-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $9.49M derived: sum of 2 quarters · filed 2026-03-04 | $12.40M derived: sum of 3 quarters · filed 2026-03-04 | $14.33M 10-K · filed 2026-03-04 | ||||
| 2023-09-30 | $4.21M 10-Q · filed 2024-11-06 | $7.11M derived: sum of 2 quarters · filed 2024-11-06 | $9.04M 10-Q · filed 2024-11-06 | $12.57M derived: sum of 4 quarters · filed 2025-03-10 | ||||
| 2023-06-30 | $2.90M 10-Q · filed 2024-08-07 | $4.83M 10-Q · filed 2024-08-07 | $8.37M derived: sum of 3 quarters · filed 2025-03-10 | $9.84M derived: sum of 4 quarters · filed 2025-03-10 | ||||
| 2023-03-31 | $1.93M 10-Q · filed 2024-05-06 | $5.47M derived: sum of 2 quarters · filed 2025-03-10 | $6.94M derived: sum of 3 quarters · filed 2025-03-10 | $7.94M derived: sum of 4 quarters · filed 2025-03-10 | ||||
| 2022-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $5.00M derived: sum of 2 quarters · filed 2025-03-10 | $6.00M derived: sum of 3 quarters · filed 2025-03-10 | $8.25M 10-K · filed 2025-03-10 | ||||
| 2022-09-30 | $1.47M 10-Q · filed 2023-11-01 | $2.47M derived: sum of 2 quarters · filed 2023-11-01 | $4.72M 10-Q · filed 2023-11-01 | $9.38M derived: sum of 4 quarters · filed 2023-11-01 | ||||
| 2022-06-30 | $1.00M 10-Q · filed 2023-08-09 | $3.25M 10-Q · filed 2023-08-09 | $7.91M derived: sum of 3 quarters · filed 2023-08-09 | $10.83M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-08 | $6.91M derived: sum of 2 quarters · filed 2023-05-08 | $9.83M derived: sum of 3 quarters · filed 2023-05-08 | $12.50M derived: sum of 4 quarters · filed 2023-05-08 | ||||
| 2021-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $7.58M derived: sum of 2 quarters · filed 2023-03-02 | $10.25M derived: sum of 3 quarters · filed 2023-03-02 | $11.58M 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | $2.92M 10-Q · filed 2022-11-01 | $5.58M derived: sum of 2 quarters · filed 2022-11-01 | $6.92M 10-Q · filed 2022-11-01 | $12.18M derived: sum of 4 quarters · filed 2022-11-01 | ||||
| 2021-06-30 | $2.66M 10-Q · filed 2022-08-02 | $4.00M 10-Q · filed 2022-08-02 | $9.26M derived: sum of 3 quarters · filed 2022-08-02 | $13.30M derived: sum of 4 quarters · filed 2022-08-02 | ||||
| 2021-03-31 | $1.33M 10-Q · filed 2022-05-03 | $6.60M derived: sum of 2 quarters · filed 2022-05-03 | $10.64M derived: sum of 3 quarters · filed 2022-05-03 | $23.50M derived: sum of 4 quarters · filed 2022-05-03 | ||||
| 2020-12-31 | $5.27M 10-K · filed 2021-03-03 | $9.31M derived: sum of 2 quarters · filed 2021-11-02 | $22.17M derived: sum of 3 quarters · filed 2021-11-02 | $26.78M 10-K · filed 2022-03-07 | ||||
| 2020-09-30 | $4.04M 10-Q · filed 2021-11-02 | $16.90M derived: sum of 2 quarters · filed 2021-11-02 | $21.51M 10-Q · filed 2021-11-02 | $24.20M derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $12.86M 10-Q · filed 2021-08-03 | $17.47M 10-Q · filed 2021-08-03 | $20.16M derived: sum of 3 quarters · filed 2021-08-03 | $22.35M derived: sum of 4 quarters · filed 2021-08-03 | ||||
| 2020-03-31 | $4.62M 10-Q · filed 2021-05-03 | $7.31M derived: sum of 2 quarters · filed 2021-05-03 | $9.49M derived: sum of 3 quarters · filed 2021-05-03 | $11.16M derived: sum of 4 quarters · filed 2021-05-03 | ||||
| 2019-12-31 | $2.69M 10-K · filed 2021-03-03 | $2.66M 10-K · filed 2020-03-04 | $4.88M derived: sum of 2 quarters · filed 2021-03-03 | $6.54M derived: sum of 3 quarters · filed 2021-03-03 | $8.86M 10-K · filed 2021-03-03 | $8.75M 10-K · filed 2020-03-04 | ||
| 2019-09-30 | $2.19M 10-K · filed 2021-03-03 | $2.27M 10-Q · filed 2019-11-05 | $3.85M derived: sum of 2 quarters · filed 2021-03-03 | $6.17M 10-Q · filed 2020-11-04 | $6.89M 10-Q · filed 2019-11-05 | $9.08M derived: sum of 4 quarters · filed 2021-03-03 | ||
| 2019-06-30 | $1.66M 10-K · filed 2021-03-03 | $2.13M 10-Q · filed 2019-08-09 | $3.98M 10-Q · filed 2020-08-04 | $4.62M 10-Q · filed 2019-08-09 | $6.89M derived: sum of 3 quarters · filed 2021-03-03 | $9.41M derived: sum of 4 quarters · filed 2021-03-03 | ||
| 2019-03-31 | $2.32M 10-K · filed 2021-03-03 | $2.29M 10-K · filed 2020-03-04 | $5.23M derived: sum of 2 quarters · filed 2021-03-03 | $7.74M derived: sum of 3 quarters · filed 2021-03-03 | $10.03M derived: sum of 4 quarters · filed 2021-03-03 | |||
| 2018-12-31 | $2.92M 10-K · filed 2020-03-04 | $5.43M derived: sum of 2 quarters · filed 2020-03-04 | $7.71M derived: sum of 3 quarters · filed 2020-03-04 | $10.06M 10-K · filed 2020-03-04 | ||||
| 2018-09-30 | $2.51M 10-K · filed 2020-03-04 | $2.72M 10-Q · filed 2019-11-05 | $4.80M derived: sum of 2 quarters · filed 2020-03-04 | $7.73M 10-Q · filed 2019-11-05 | ||||
| 2018-06-30 | $2.29M 10-K · filed 2020-03-04 | $2.56M 10-Q · filed 2019-08-09 | $5.02M 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | $2.34M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |